Day, marked on 24 March, the World Health Organization (WHO) is calling for an urgent investment of resources to protect and maintain tuberculosis (TB) care and support services for people in need ...

As of early 2025, tuberculosis cases are increasing in the U.S. This disease causes significant lung damage and, if not treated, is almost always lethal. World TB Day on March 24 raises awareness ...

Tuberculosis, an ongoing pandemic, highlights and exacerbates global disparities. With the prevailing model of standardised treatment in vertical health programmes, it is unsurprising that ...

Tuberculosis continues to cause a substantial amount of morbidity globally, with nearly 11 million people having active tuberculosis in 2023.1 Success rates for tuberculosis treatment have improved ...

Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...

The treatment of TB involves a combination of several antibiotics. These are aimed at reducing the risk of transmission, ...

Leading UCSF physician-scientists are developing targeted treatments, earlier diagnostics, and helping to solve tuberculosis’ ...

Background The broad-spectrum antiparasitic drug ivermectin is widely used in children, and its use in children weighing < 15 kg is off-label, as little data is available to inform the use of ...

The dosage for Abilify (aripiprazole) may depend on the condition being treated and the form of the drug prescribed. Other factors, including your age and how you respond to treatment, may affect ...

Quercetin has most often been used by adults in doses of 250-1000 mg by mouth daily for up to 12 weeks. Speak with a healthcare provider to find out what dose might be best for a specific condition.

Objective: To determine the post-marketing safety profile of a once-daily fixed-dose combination (FDC) of dapagliflozin (10 mg) and saxagliptin (5 mg) given orally for 24 weeks or until ...